发明名称 IgE ANTIBODIES FOR THE INHIBITION OF TUMOR METASTASIS
摘要 The present invention provides novel IgE antibodies useful for inhibiting or preventing metastatic cancer. Also provided are methods to inhibit tumor metastasis by modulating the activity of at least one non-tumor cell, treating a patient to inhibit or prevent tumor metastases of a primary solid tumor, treating metastatic carcinoma, reducing metastasis of carcinoma cells, and reducing the growth kinetics of a primary solid tumor or a metastasized cell or tumor.
申请公布号 US2014370001(A1) 申请公布日期 2014.12.18
申请号 US201313939781 申请日期 2013.07.11
申请人 The Board of Trustees of the Leland Stanford Junior University 发明人 Mollick Joseph A.;Teo Pearline;Utz Paul J.
分类号 C07K16/28 主分类号 C07K16/28
代理机构 代理人
主权项 1. A method for reprogramming the activity of at least one host-derived, non-tumor cell located in the microenvironment of a solid tumor in a patient wherein the ability of the non-tumor cell to mediate metastases of the tumor is inhibited, comprising the step of administering an IgE antibody specific for a tumor-associated antigen, wherein the antibody forms a ternary complex within the microenvironment of the tumor, said ternary complex being comprised of the IgE antibody, the tumor-associated antigen, and a host-derived, non-tumor cell endogenous to the tumor environment wherein the antibody specifically binds to the tumor-associated antigen and an antibody receptor specific for IgE located on the surface of the host-derived non-tumor cell.
地址 Palo Alto CA US